Literature DB >> 23022728

Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness.

Etienne Dardenne1, Sandra Pierredon, Keltouma Driouch, Lise Gratadou, Magali Lacroix-Triki, Micaela Polay Espinoza, Eleonora Zonta, Sophie Germann, Hussein Mortada, Jean-Philippe Villemin, Martin Dutertre, Rosette Lidereau, Stéphan Vagner, Didier Auboeuf.   

Abstract

Both epigenetic and splicing regulation contribute to tumor progression, but the potential links between these two levels of gene-expression regulation in pathogenesis are not well understood. Here, we report that the mouse and human RNA helicases Ddx17 and Ddx5 contribute to tumor-cell invasiveness by regulating alternative splicing of several DNA- and chromatin-binding factors, including the macroH2A1 histone. We show that macroH2A1 splicing isoforms differentially regulate the transcription of a set of genes involved in redox metabolism. In particular, the SOD3 gene that encodes the extracellular superoxide dismutase and plays a part in cell migration is regulated in an opposite manner by macroH2A1 splicing isoforms. These findings reveal a new regulatory pathway in which splicing factors control the expression of histone variant isoforms that in turn drive a transcription program to switch tumor cells to an invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022728     DOI: 10.1038/nsmb.2390

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  59 in total

Review 1.  Multiple facets of the unique histone variant macroH2A: from genomics to cell biology.

Authors:  Matthew J Gamble; W Lee Kraus
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 2.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

3.  Splicing regulates NAD metabolite binding to histone macroH2A.

Authors:  Georg Kustatscher; Michael Hothorn; Céline Pugieux; Klaus Scheffzek; Andreas G Ladurner
Journal:  Nat Struct Mol Biol       Date:  2005-06-19       Impact factor: 15.369

4.  The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing.

Authors:  Matthew J Gamble; Kristine M Frizzell; Christine Yang; Raga Krishnakumar; W Lee Kraus
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

5.  The histone variant macroH2A is an epigenetic regulator of key developmental genes.

Authors:  Marcus Buschbeck; Iris Uribesalgo; Indra Wibowo; Pau Rué; David Martin; Arantxa Gutierrez; Lluís Morey; Roderic Guigó; Hernán López-Schier; Luciano Di Croce
Journal:  Nat Struct Mol Biol       Date:  2009-09-06       Impact factor: 15.369

Review 6.  Helicases: an overview.

Authors:  Mohamed Abdelhaleem
Journal:  Methods Mol Biol       Date:  2010

7.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

8.  RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.

Authors:  Daojing Wang; Jing Huang; Zhi Hu
Journal:  Mol Cell Proteomics       Date:  2011-11-15       Impact factor: 5.911

9.  Regulation of cancer invasion by reactive oxygen species and Tks family scaffold proteins.

Authors:  Alissa M Weaver
Journal:  Sci Signal       Date:  2009-09-15       Impact factor: 8.192

10.  SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.

Authors:  A-M F Jacobs; S M Nicol; R G Hislop; E G Jaffray; R T Hay; F V Fuller-Pace
Journal:  Oncogene       Date:  2007-03-19       Impact factor: 9.867

View more
  65 in total

Review 1.  The DDX5/Dbp2 subfamily of DEAD-box RNA helicases.

Authors:  Zheng Xing; Wai Kit Ma; Elizabeth J Tran
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-12-02       Impact factor: 9.957

Review 2.  Histone variants: emerging players in cancer biology.

Authors:  Chiara Vardabasso; Dan Hasson; Kajan Ratnakumar; Chi-Yeh Chung; Luis F Duarte; Emily Bernstein
Journal:  Cell Mol Life Sci       Date:  2013-05-08       Impact factor: 9.261

3.  PARP1 and CBP lose their footing in cancer.

Authors:  Gyula Timinszky; Andreas G Ladurner
Journal:  Nat Struct Mol Biol       Date:  2014-11       Impact factor: 15.369

Review 4.  Variants of core histones and their roles in cell fate decisions, development and cancer.

Authors:  Marcus Buschbeck; Sandra B Hake
Journal:  Nat Rev Mol Cell Biol       Date:  2017-02-01       Impact factor: 94.444

Review 5.  Solid tumours hijack the histone variant network.

Authors:  Flávia G Ghiraldini; Dan Filipescu; Emily Bernstein
Journal:  Nat Rev Cancer       Date:  2021-02-10       Impact factor: 60.716

6.  RNA splicing: Layered regulation.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

Review 7.  Macro domains as metabolite sensors on chromatin.

Authors:  Melanija Posavec; Gyula Timinszky; Marcus Buschbeck
Journal:  Cell Mol Life Sci       Date:  2013-03-03       Impact factor: 9.261

Review 8.  The roles of histone variants in fine-tuning chromatin organization and function.

Authors:  Sara Martire; Laura A Banaszynski
Journal:  Nat Rev Mol Cell Biol       Date:  2020-07-14       Impact factor: 94.444

Review 9.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

Authors:  A Sveen; S Kilpinen; A Ruusulehto; R A Lothe; R I Skotheim
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

Review 10.  Histone variants: the tricksters of the chromatin world.

Authors:  Catherine Volle; Yamini Dalal
Journal:  Curr Opin Genet Dev       Date:  2014-01-24       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.